Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

According to Mochi Health, more than half of its patients lose at least 10% of their body weight within the first six months, ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a ...

An expert explains how the new program, which launches July 1, will work and who is eligible ...

Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...

The medical community has fundamentally redefined its approach to obesity, transitioning from purely behavioral interventions to highly sophisticated pharmacological treatments. In recent years, a ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a ...

GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are ...